in this issue
Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndrome
Is carboplatin–paclitaxel combination the standard treatment of elderly ovarian cancer patients?
Second consensus on medical treatment of metastatic breast cancer
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis
Components of the metabolic syndrome in long-term survivors of testicular cancer
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
Prognostic significance of stromal versican expression in human endometrial cancer
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer—a study by the AGO OVAR Germany
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
Phase II study of gemcitabine–dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors
Suicide and cancer: a gender-comparative study
Dietary intake of fruit and vegetable and lung cancer risk: a case–control study in Harbin, northeast China
The cost-effectiveness of bisphosphonates in metastatic breast cancer: letter to the editor in response to Botteman et al. 2006
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery
International Association for Hospice and Palliative Care list of essential medicines for palliative care
Rasburicase-induced fatal respiratory arrest?
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Phase II studies of anticancer chemotherapy: indirect evidence of poor quality
What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?